Eli Lilly interview: Innovation and compliance, active ingredients
有效成分
| BY
Katherine JoJane Huang, general counsel and VP of legal at Eli Lilly China, discusses the importance of R&D, communicating with HQ and employees, instilling a compliance culture and keeping up with the evolving healthcare industry. 礼来中国总法律顾问兼法务部副总裁黄洁莹探讨研发、与总部和员工沟通、培育合规文化以及与不断变化的医疗行业保持同步发展的重要性。
Can you describe your legal team? How many offices and facilities in China do you oversee?
I am the general counsel and VP of legal at Eli Lilly and Company. Lilly began building a locally-based legal team about 10 years ago; I joined in 2009. We currently have six lawyers on our team covering a wide range of issues related to general company law and healthcare.
This premium content is reserved for
China Law & Practice Subscribers.
A Premium Subscription Provides:
- A database of over 3,000 essential documents including key PRC legislation translated into English
- A choice of newsletters to alert you to changes affecting your business including sector specific updates
- Premium access to the mobile optimized site for timely analysis that guides you through China's ever-changing business environment
Already a subscriber? Log In Now
For enterprise-wide or corporate enquiries, please contact our experienced Sales Professionals at +44 (0)203 868 7546 or ChinaLawPracticeSubs@alm.com